{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:44:41Z","timestamp":1791931481469,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"The Geoff and Helen Handbury Foundation"},{"name":"The Beischer Medical Foundation for Mothers and Babies"},{"name":"The Mercy Perinatal Foundation"},{"name":"The Kilvington Trust"},{"name":"National Health and Medical Research Foundation of Australia"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajog.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.ajog.2018.07.019","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T03:51:40Z","timestamp":1532577100000},"page":"388.e1-388.e17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["Esomeprazole to treat women with preterm preeclampsia: a randomized placebo controlled trial"],"prefix":"10.1016","volume":"219","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0406-8964","authenticated-orcid":false,"given":"Catherine A.","family":"Cluver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie J.","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"van Papendorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hiscock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Beard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben W.","family":"Mol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard B.","family":"Theron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric H.","family":"Decloedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0806-9734","authenticated-orcid":false,"given":"Marietjie","family":"Stander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim T.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Rensburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan P.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2018.07.019_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","article-title":"Global and regional estimates of preeclampsia and eclampsia: a systematic review","volume":"170","author":"Abalos","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2018.07.019_bib2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","article-title":"The global impact of pre-eclampsia and eclampsia","volume":"33","author":"Duley","year":"2009","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.ajog.2018.07.019_bib3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/01.AOG.0000253215.79121.75","article-title":"Predictors of neonatal outcome in early- onset placental dysfunction","volume":"109","author":"Baschat","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.07.019_bib4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2018.07.019_bib5","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1161\/CIRCULATIONAHA.109.853127","article-title":"Preeclampsia, a disease of the maternal endothelium the role of antiangiogenic factors and implications for later cardiovascular disease","volume":"123","author":"Powe","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2018.07.019_bib6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/HYPERTENSIONAHA.116.08408","article-title":"Proton pump inhibitors decrease soluble fms-like tyrosine kinase-1 and soluble endoglin secretion, decrease hypertension, and rescue endothelial dysfunction","volume":"69","author":"Onda","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2018.07.019_bib7","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/HYPERTENSIONAHA.117.09741","article-title":"Low soluble fms-like tyrosine kinase-1, endoglin, and endothelin-1 levels in women with confirmed or suspected preeclampsia using proton pump inhibitors","volume":"70","author":"Saleh","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2018.07.019_bib8","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1046\/j.1365-2036.2001.01087.x","article-title":"Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole","volume":"15","author":"Andersson","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ajog.2018.07.019_bib9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10620-011-1940-3","article-title":"The safety of fetal exposure to proton-pump inhibitors during pregnancy","volume":"57","author":"Matok","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ajog.2018.07.019_bib10","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/ajg.2009.122","article-title":"The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis","volume":"104","author":"Gill","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ajog.2018.07.019_bib11","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1056\/NEJMoa1002689","article-title":"Use of proton-pump inhibitors in early pregnancy and the risk of birth defects","volume":"363","author":"Pasternak","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2018.07.019_bib12","doi-asserted-by":"crossref","first-page":"e008211","DOI":"10.1136\/bmjopen-2015-008211","article-title":"Double blind, randomised, placebo-controlled trial to evaluate the efficacy of esomeprazole to treat early onset pre-eclampsia (PIE Trial): a study protocol","volume":"5","author":"Cluver","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2018.07.019_bib13","first-page":"22","article-title":"Understanding expectant management of pre-eclampsia","volume":"26","author":"Hall","year":"2016","journal-title":"Obstet Gynaecol Forum"},{"key":"10.1016\/j.ajog.2018.07.019_bib14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J\u00a0Biomed Inform"},{"key":"10.1016\/j.ajog.2018.07.019_bib15","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/j.1471-0528.2000.tb11616.x","article-title":"Expectant management of early onset, severe pre-eclampsia: maternal outcome","volume":"107","author":"Hall","year":"2000","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2018.07.019_bib16","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s002280000206","article-title":"Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects","volume":"56","author":"Hassan-Alin","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2018.07.019_bib17","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jpha.2016.01.001","article-title":"Development and validation of a high throughput UPLC\u2013MS\/MS method for simultaneous quantification of esomeprazole, rabeprazole and levosulpiride in human plasma","volume":"6","author":"Chunduri","year":"2016","journal-title":"J\u00a0Pharm Anal"},{"key":"10.1016\/j.ajog.2018.07.019_bib18","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1023\/A:1015009300955","article-title":"Effect of esomeprazole 40 mg vs omeprazole 40\u00a0mg on 24-hour intragastric ph in patients with symptoms of gastroesophageal reflux disease","volume":"47","author":"R\u00f6hss","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ajog.2018.07.019_bib19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ajog.2018.07.019_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12884-016-0902-3","article-title":"Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta","volume":"16","author":"Brownfoot","year":"2016","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ajog.2018.07.019_bib21","doi-asserted-by":"crossref","first-page":"356.e1","DOI":"10.1016\/j.ajog.2015.12.019","article-title":"Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction","volume":"214","author":"Brownfoot","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.07.019_bib22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/HYPERTENSIONAHA.115.05445","article-title":"Effects of pravastatin on human placenta, endothelium, and women with severe preeclampsia","volume":"66","author":"Brownfoot","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2018.07.019_bib23","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1038\/s41598-017-01993-w","article-title":"Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction - implications as a preeclampsia treatment","volume":"7","author":"Hannan","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajog.2018.07.019_bib24","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/CIRCULATIONAHA.111.034793","article-title":"Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia","volume":"124","author":"Thadhani","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2018.07.019_bib25","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/AOG.0000000000001727","article-title":"Perinatal and hemodynamic evaluation of sildenafil citrate for preeclampsia treatment","volume":"128","author":"Vigil-De Gracia","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.07.019_bib26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/aji.12091","article-title":"Exploring the role of antithrombin replacement for the treatment of preeclampsia: a prospective randomized evaluation of the safety and efficacy of recombinant antithrombin in very preterm preeclampsia (PRESERVE-1)","volume":"69","author":"Paidas","year":"2013","journal-title":"Am J Reprod Immunol"},{"issue":"suppl","key":"10.1016\/j.ajog.2018.07.019_bib27","doi-asserted-by":"crossref","first-page":"S559","DOI":"10.1016\/j.ajog.2016.11.1048","article-title":"LB02: randomized double-blind placebo controlled evaluation of the safety and efficacy of recombinant antithrombin vs placebo in preterm preeclampsia","volume":"216","author":"Sibai","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.07.019_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.thromres.2016.01.024","article-title":"High dose antithrombin supplementation in early preeclampsia: a randomized, double blind, placebo-controlled study","volume":"140","author":"D\u2019Angelo","year":"2016","journal-title":"Thromb Res"}],"updated-by":[{"DOI":"10.1016\/j.ajog.2023.07.026","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000}}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937818306069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937818306069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T17:06:30Z","timestamp":1720458390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937818306069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0002937818306069"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2018.07.019","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ajog.2023.07.026","asserted-by":"object"}]},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Esomeprazole to treat women with preterm preeclampsia: a randomized placebo controlled trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2018.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}